Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $6.85 Million - $9.17 Million
42,523 New
42,523 $8.1 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $13.4 Million - $16.7 Million
76,605 Added 159.59%
124,605 $27 Million
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $9.81 Million - $14.2 Million
48,000 New
48,000 $9.87 Million
Q2 2020

Aug 14, 2020

SELL
$27.25 - $47.53 $565,110 - $985,677
-20,738 Reduced 32.55%
42,970 $2.04 Million
Q4 2019

Feb 14, 2020

SELL
$29.4 - $44.98 $1.31 Million - $2 Million
-44,560 Reduced 41.16%
63,708 $2.8 Million
Q3 2019

Nov 14, 2019

BUY
$29.71 - $55.23 $2.62 Million - $4.87 Million
88,238 Added 440.53%
108,268 $3.24 Million
Q2 2019

Aug 14, 2019

SELL
$29.73 - $66.02 $1.49 Million - $3.31 Million
-50,182 Reduced 71.47%
20,030 $0
Q1 2019

May 15, 2019

BUY
$29.41 - $38.1 $2.06 Million - $2.68 Million
70,212 New
70,212 $0

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.